LY4213663 Clinical Trials (2026): 1 Studies for Healthy & Rheumatoid Arthritis (RA)
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 LY4213663 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy & Rheumatoid Arthritis (RA)) and 141 total planned enrollment. 1 LY4213663 clinical trial is actively recruiting at 9 U.S. sites across 4 states. Most recent activity: NCT07258849 (Mar 2028).
Where to Participate: All LY4213663 Trial Sites in the U.S. (9 sites across 4 states)
Every actively recruiting LY4213663trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | Pinnacle Research Group, LLC | Anniston36207 | NCT07258849 | Map |
| AZ | Arizona Research Center | Phoenix85053 | NCT07258849 | Map |
| FL | Clinical Research of West Florida, Inc. (Clearwater) | Clearwater33765 | NCT07258849 | Map |
| FL | GNP Research at Mark Jaffe, MD | Cooper City33024 | NCT07258849 | Map |
| FL | Fortrea Clinical Research Unit | Daytona Beach32117 | NCT07258849 | Map |
| FL | AGA Clinical Trials | Hialeah33012 | NCT07258849 | Map |
| FL | Advanced Pharma CR, LLC | Miami33417 | NCT07258849 | Map |
| FL | Floridian Clinical Research | Miami Lakes33016 | NCT07258849 | Map |
| NV | Oasis Clinical Research | Las Vegas89121 | NCT07258849 | Map |
LY4213663 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting LY4213663 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07258849 | A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis | P1 | Rheumatoid Arthritis (RA) | 141 | Dec 2025 |
All LY4213663 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07258849 | A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis | P1 | recruiting | 141 | Eli Lilly and Company | Dec 2025 |
LY4213663 clinical trials: frequently asked questions
- How many LY4213663 clinical trials are there?
- 1 LY4213663 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are LY4213663 clinical trials recruiting in 2026?
- Yes — 1 LY4213663 trial is actively recruiting in 2026, with 9 U.S. sites across 4 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is LY4213663 being studied for?
- LY4213663 is being studied for Healthy, Rheumatoid Arthritis (RA). The trials are grouped by indication on this page.
- What phase is LY4213663 in?
- LY4213663 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY4213663 clinical trials?
- The lead sponsor across the most LY4213663 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY4213663as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: